Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Ophthalmology
|
February 1, 1997
Validation of a questionnaire for comparing the tolerability of ophthalmic medications
B L Barber, E R Strahlman, R Laibovitz, et al.
The New England Journal of Medicine
|
March 14, 1985
Evaluation of an analogue of somatostatin (L363,586) in Alzheimer's disease
N R Cutler, J V Haxby, P K Narang, et al.
Archives of Neurology
|
November 1, 1996
Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group
W H Visser, G M Terwindt, S A Reines, et al.
Clinical Pharmacokinetics
|
March 1, 1992
Pharmacokinetics and dose proportionality of D2-agonist MK-458 (HPMC) in parkinsonism
N R Cutler, S A Reines, L F McLean, et al.
Life Sciences
|
January 1, 1995
A multiple-dose safety trial of eptastigmine in Alzheimer's disease, with pharmacodynamic observations of red blood cell cholinesterase
J J Sramek, G A Block, S A Reines, et al.
Cephalalgia : an International Journal of Headache
|
April 1, 1996
Pilot study of MK-462 in migraine
N R Cutler, J Claghorn, J J Sramek, et al.
Headache
|
April 4, 2001
Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group
P Tfelt-Hansen, J Teall, F Rodriguez, et al.
Neurology
|
January 14, 2004
Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study
S A Reines, G A Block, J C Morris, et al.
Neurology
|
September 25, 1998
A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group
M S Kramer, D Matzura-Wolfe, A Polis, et al.
Headache
|
December 23, 2004
Pharmacokinetics of rizatriptan tablets during and between migraine attacks
N R Cutler, S S Jhee, A K Majumdar, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Ophthalmology
|
February 1, 1997
Validation of a questionnaire for comparing the tolerability of ophthalmic medications
B L Barber, E R Strahlman, R Laibovitz, et al.
The New England Journal of Medicine
|
March 14, 1985
Evaluation of an analogue of somatostatin (L363,586) in Alzheimer's disease
N R Cutler, J V Haxby, P K Narang, et al.
Archives of Neurology
|
November 1, 1996
Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group
W H Visser, G M Terwindt, S A Reines, et al.
Clinical Pharmacokinetics
|
March 1, 1992
Pharmacokinetics and dose proportionality of D2-agonist MK-458 (HPMC) in parkinsonism
N R Cutler, S A Reines, L F McLean, et al.
Life Sciences
|
January 1, 1995
A multiple-dose safety trial of eptastigmine in Alzheimer's disease, with pharmacodynamic observations of red blood cell cholinesterase
J J Sramek, G A Block, S A Reines, et al.
Cephalalgia : an International Journal of Headache
|
April 1, 1996
Pilot study of MK-462 in migraine
N R Cutler, J Claghorn, J J Sramek, et al.
Headache
|
April 4, 2001
Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group
P Tfelt-Hansen, J Teall, F Rodriguez, et al.
Neurology
|
January 14, 2004
Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study
S A Reines, G A Block, J C Morris, et al.
Neurology
|
September 25, 1998
A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group
M S Kramer, D Matzura-Wolfe, A Polis, et al.
Headache
|
December 23, 2004
Pharmacokinetics of rizatriptan tablets during and between migraine attacks
N R Cutler, S S Jhee, A K Majumdar, et al.
Page
of 3